5 Stocks to Watch: Week of 6/29/2026

A happy weekend to you! We've got a great list of stocks to watch in the coming week:

• General Dynamics (GD) — Defense titan rides $125B Navy submarine windfall.
• Calix (CALX) — Broadband infrastructure play targets +73% upside potential.
• Levi Strauss & Co (LEVI) — Iconic denim brand crushes Q1 with 14% revenue surge.
• HubSpot (HUBS) — Beaten-down SaaS leader targets jaw-dropping 56% upside ahead.
• Ani Pharmaceuticals (ANIP) — Rare disease leader eyes 50% upside ahead.

P.S. Want a bonus pick every week? Join our weekly Live training at 7pm every Monday to access our Editor-in-Chief’s Trade of the Week. Sign up for the next one here (completely complimentary!)

1- General Dynamics (NYSE: GD)

With Gulfstream business jets, Virginia- and Columbia-class nuclear submarines, and Arleigh Burke-class destroyers in its portfolio — plus a $125B Navy submarine acquisition program through 2031 — the marine division of this defense stock is poised for continued margin expansion as geopolitical tensions drive defense spending.

Zen Rating: A (Strong Buy) — see full analysis

Recent Price: $345.05 — get current quote

Max 1-year forecast: $400.00

Why we're watching:

• Analyst support: The stock has overall strong support, with 4 Strong Buy and 3 Hold recommendations. See the recommendations here
• Jefferies analyst Sheila Kahyaoglu (a top 11% rated analyst) recently upgraded the stock to Strong Buy with a $400 price target following the company's exceptional marine segment performance.
• According to Kahyaoglu, eleven out of General Dynamics' past thirteen quarters have seen double-digit growth in the marine market, which accounts for 33% of its sales, with the U.S. Navy allocating $125B for submarine acquisition between FY 2027 and 2031 plus an additional $6.2B for the submarine industrial base.
• Zen Rating highlights: GD earns an overall Zen Rating of A, a Strong Buy recommendation. This means that following a 115-factor review, this stock ranks in the top 5% of all 4600+ stocks tracked. 
• Component Grades: The stock shows balanced strength among the Component Grades, with an A for Safety and strong Bs for Financials, Sentiment, Value, and from our proprietary AI factor, which digs deeper than most humans to detect subtle signs of potential outperformance. See all 7 Component Grades here

2- Levi Strauss & Co (NYSE: LEVI)

A legendary American brand is reinventing itself for the modern shopper. Levi Strauss — the iconic designer, marketer, and seller of jeans, casual wear, and related accessories globally — is executing a transformation into a DTC-first denim lifestyle brand, delivering strong Q1 2026 results with 14% revenue growth and raising full-year guidance.

Zen Rating: A (Strong Buy) — see full analysis

Recent Price: $23.76 — get current quote

Max 1-year forecast: $34.00

Why we're watching:

• Analyst support: LEVI enjoys unanimous bullish sentiment from Wall Street’s brightest and best minds — all the current recommendations among analysts we track are Buy or better. See them here
• For example, UBS researcher Jay Sole (a top 6% rated analyst) recently raised his price target to $34 (suggesting 44% upside potential) following Q1 earnings, noting the company's transformation will support mid-single-digit revenue growth with mid-teens margins over time.
• In his detailed analyst commentary following the strong Q1 beat, Sole highlighted management's comment that "we delivered very strong financial performance in the first quarter, driven by broad-based growth across channels, regions, and categories" with EPS of $0.42 beating estimates by 14%.
• Industry ranking context: Levi Strauss is currently the #1 highest-rated stock in the Apparel Manufacturing industry, which has an Industry Rating of A, positioning it as the sector leader.
• Zen Rating highlights: LEVI earns an overall Zen Rating of A, a Strong Buy recommendation. This is a class of stocks that have historically trounced the S&P 500 with average annual returns of nearly 30% over the past 20 years. 
• Component Grades: The company demonstrates impressive strength with B Grades for Growth, Sentiment, Safety, and Financials, while Value, Momentum, and AI score C Grades — reflecting balanced fundamentals with room to improve in valuation and momentum metrics. See all 7 Component Grades here

3- HubSpot (NYSE: HUBS)

Projected earnings growth exceeding 600% year-over-year is a number that's hard to ignore. HubSpot offers software products for inbound marketing, sales, and customer service, addressing CRM, social media marketing, and content management needs — and trading near its 52-week low after significant pullback, the company presents a compelling opportunity with strong analyst support behind it.

Zen Rating: A (Strong Buy) — see full analysis

Recent Price: $171.55 — get current quote

Max 1-year forecast: $442.00

Why we're watching:

• Analyst support: HUBS commands significant Wall Street attention with 24 analysts covering the stock, including 14 Strong Buy, 5 Buy, 4 Hold, and only 1 Sell recommendation, establishing a Strong Buy consensus. See them here
• For example, Barclays researcher Raimo Lenschow (a top 3% rated analyst) recently maintained his Strong Buy rating with a $270 price target, representing 49% upside potential from current levels.
• Interestingly, as a look on the flip side, Citigroup's Tyler Radke (a top 23% rated analyst) downgraded the stock to Hold with a $230 price target following recent market volatility, though this still implies 27% upside.
• Industry ranking context: HubSpot is currently the 15th highest-rated stock in the App industry, which has an Industry Rating of B.
• Zen Rating highlights: As an A or Strong Buy-rated stock, HUBS demonstrates strength across our 115-factor fundamental review, landing it in the top 5% of the 4600+ stocks we track. These are stocks with the highest likelihood of outperformance according to our model. 
• Component Grades: The stock demonstrates balanced strength across key metrics with Growth (A) and Sentiment (B) leading the way, while Value scores B and Financials earn B grades, indicating solid fundamental support despite recent price weakness. See all 7 Component Grades here

4- Ani Pharmaceuticals (NASDAQ: ANIP)

Cortrophin Gel is fueling a quiet transformation at ANI Pharmaceuticals. The biopharmaceutical company concentrates on the development, production, and commercialization of both proprietary branded and generic pharmaceutical products — and the company is now driving growth through its rare disease franchise, with Cortrophin Gel leading the charge in 2026.

Zen Rating: A (Strong Buy) — see full analysis

Recent Price: $84.93 — get current quote

Max 1-year forecast: $124.00

Why we're watching:

• Analyst support: While coverage is very slim with just 1 recommendation at present, it’s bullish: ANIP receives a Strong Buy recommendation with a compelling $124 price target representing 50% upside potential from current levels. See forecast updates here
• That’s from Guggenheim researcher Vamil Divan (a top 4% rated analyst), who maintains his Strong Buy rating with a $124 price target, reflecting confidence in the company's rare disease strategy and Cortrophin Gel's commercial trajectory.
• The stock trades at an attractive valuation of just 9.8x forward earnings despite strong growth prospects, with analysts projecting EPS growth of 134% in the coming year driven by the rare disease portfolio expansion.
• Industry ranking context: ANI Pharmaceuticals is currently the 3rd highest-rated stock in the Pharmaceutical industry, which has an Industry Rating of B, demonstrating strong relative positioning in a quality sector.
• Zen Rating highlights: ANIP earns an overall Strong Buy recommendation from the Zen Ratings, with a grade of A. Only the top 5% of stocks tracked are in this tier! 
• Component Grades: The company shows balanced strength with Value earning an A grade, Sentiment and Financials both receiving B grades, reflecting positive analyst and market perception of the company's strategic direction. See all 7 Component Grades here

5- Calix (NYSE: CALX)

America's fiber and broadband buildout is creating massive opportunities for the picks-and-shovels providers — and Calix is leading the pack. The company provides cloud and software platforms, systems, and services to broadband providers, and despite recent legal headlines, top-tier analysts see exceptional upside potential of +73% as digital infrastructure deployment accelerates across North America.

Zen Rating: A (Strong Buy) — see full analysis

Recent Price: $35.20 — get current quote

Max 1-year forecast: $70.00

Why we're watching:

• Analyst support: Wall Street is highly bullish with 2 Strong Buy and 1 Buy recommendation from 3 analysts covering the stock, representing unanimous positive sentiment. See them here
• For instance, Rosenblatt's Mike Genovese (a top 1% rated analyst) recently maintained his Strong Buy recommendation with a $70 price target (suggesting over 91% upside potential in the coming year), emphasizing the company’s high potential as the digital landscape continues to evolve and demand for the company's services strengthens.
• Needham researcher Ryan Koontz (top 1%) also recently maintained a Buy recommendation, noting the company's consistent revenue growth and expanding market share position it well for continued strong performance.
• Industry ranking context: Calix is currently the 7th highest-rated stock in the App industry, which has an Industry Rating of B.
• Zen Rating highlights: CALX currently ranks in the top 5% of stocks we track based on Fundamentals, earning an overall Zen Rating of A, a Strong Buy recommendation. It shines with an A for Growth and Bs for Financials and Value. See all 7 Component Grades here

What to Do Next?

• 77 Best Stocks NOW! >
• Options Trading with the Zen Ratings >
• 2 New Stocks to Buy from Steve Reitmeister >

Want to get in touch? Email us at news@wallstreetzen.com.